Vynleads Bets on AI Coach to Tackle Daily Diabetes Management

ROCK HILL, SC – February 11, 2026 – Vynleads (OTCQB: VYND) today launched its Done With Diabetes™ app, staking its claim in the burgeoning digital health market with an AI-powered platform aimed at transforming the daily lives of individuals with type 2 diabetes and prediabetes. The mobile app, built on a subscription model, promises to bridge the critical gap between infrequent clinical visits and the hundreds of daily decisions that truly shape metabolic health.

For a company facing significant financial headwinds, this launch represents more than just a new product; it's a pivotal move to establish a foothold in the competitive wellness technology space. The app combines personalized coaching, structured routines, and community support, aiming to make sustainable lifestyle change not just possible, but practical.

“We designed this platform for the reality of diabetes—it’s managed day by day,” said Alex Mannine, Co-Founder and CEO of Vynleads, in the company's announcement. “Done With Diabetes™ gives people a clear plan they can follow, with personalized guidance that adapts as they build momentum, plus a Community supported by AI Agents and peers so no one feels alone between appointments. The goal is simple: make progress sustainable.”

The AI-Powered Approach to Daily Wellness

At the core of the Done With Diabetes™ app is Vynleads’ proprietary Lifestyle Blueprint™, an AI engine designed to deliver a deeply personalized experience. Upon onboarding, the app tailors daily targets, habits, and focus areas to the user's specific goals and lifestyle. This personalization is not static; it continuously adapts based on user actions and feedback throughout a structured 8-week program and beyond.

This approach taps into a growing body of evidence supporting the efficacy of AI in chronic disease management. Studies have shown that integrated digital health platforms can lead to significant clinical improvements. For instance, a 48-week randomized controlled trial demonstrated that AI-driven dietary management led to greater reductions in HbA1c levels and more weight loss in adults with Type 2 Diabetes compared to routine care. AI-powered personalized notifications have also been shown to triple patient engagement in some settings.

Inside the app, this manifests as the “Dr. Smith AI Wellness Coach,” a context-aware conversational agent. It's designed to help users with practical, real-world challenges like meal swaps, planning for social events, and finding motivation during setbacks. This is coupled with an 8-week “Success Blueprint” that guides users through phased modules, progressively building skills in nutrition, lifestyle, and self-management without overwhelming them.

A High-Stakes Bet in a Crowded Market

The launch is a critical juncture for Vynleads. The company, which trades on the OTCQB market, has faced financial challenges. According to recent filings, the company reported a net loss of over $80,000 in the first quarter of 2025 with no revenue generation and held negative working capital, signaling liquidity management issues. With a market capitalization of approximately $5.79 million and a volatile stock history, the success of Done With Diabetes™ is paramount.

The company is entering a fiercely competitive digital diabetes management landscape. It will vie for users against established players like Livongo by Teladoc Health, which often comes free to users through employer and health plan partnerships, and popular consumer apps like mySugr and One Drop. Other competitors, such as Welldoc's BlueStar, are recognized as prescription Digital Therapeutics (DTx), having undergone rigorous clinical validation to prove their therapeutic benefit.

Vynleads is positioning its app with a direct-to-consumer subscription of $29 per month following a 7-day free trial. Its key differentiators are the depth of its AI personalization, the structured journey from an 8-week program into an ongoing “Lifetime Wellness Mode,” and an AI-enhanced community. This long-term support model is designed to prevent the habit regression and user drop-off that often follow short-term programs.

From Clinical Data to Real-World Support

While the technology and business strategy are complex, the app's promise to users is one of simplicity and empowerment. It aims to translate abstract lifestyle medicine principles into a simple, repeatable daily experience. This is achieved through a suite of features designed to reduce decision fatigue and make healthy choices easier.

The app includes a curated library of over 43 diabetes-friendly recipes, complete with nutritional data and shopping lists. Progress dashboards allow users to track not just clinical metrics but also lifestyle factors like energy levels, stress, sleep quality, and hydration. To foster consistency, Vynleads has incorporated gamification elements such as points, streaks, a “Daily Spin,” and a “Wellness Garden” that visually represents a user's adherence over time.

A significant component is the community, which includes forums for sharing victories, weekly challenges, and buddy matching. Uniquely, Vynleads is deploying AI Agents within the community to respond to user posts, offer encouragement, and guide users to relevant content. The company states these agents operate within clear wellness guardrails and with transparency, aiming to keep the community active and supportive without replacing peer-to-peer interaction.

The Road Ahead: Enterprise and Expansion

While the initial launch targets individual consumers, Vynleads' long-term strategy hinges on expansion. The company has explicitly stated its plans to pursue enterprise partnerships with self-insured employers, health plans, and healthcare systems. This B2B model has been a lucrative path for competitors, as employers and payers increasingly invest in digital tools to manage chronic conditions, reduce healthcare costs, and boost productivity.

Furthermore, Done With Diabetes™ is envisioned as the first in a series of “Done With (DWX)” programs. The underlying platform—the Lifestyle Blueprint™ engine, AI coaching, and community framework—is designed to be adapted for other chronic, lifestyle-driven health challenges. This positions Vynleads not just as a single-product company but as a scalable digital wellness platform.

For now, the app is intended for general wellness and educational purposes, a crucial distinction that keeps it outside the more stringent regulatory requirements for medical devices. As the app rolls out and begins to gather user data and testimonials, Vynleads will face the dual challenge of proving its value to both individual subscribers and potential enterprise clients, all while navigating its own financial recovery in a market that is both promising and unforgiving.